← All indications
Calcinosis
Pathologic deposition of calcium salts in tissues.
Subtype terms (5)
More specific conditions that are subtypes of Calcinosis in the MeSH hierarchy.
- Calcinosis Cutis
- Calciphylaxis
8 drugs (3 approved, 5 experimental)
- CREST Syndrome
2 drugs (1 approved, 1 experimental)
- Nephrocalcinosis
3 drugs (2 approved, 1 experimental)
- Vascular Calcification
35 drugs (25 approved, 10 experimental)
Drugs by status
Phase 4 trials (4)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 4 Indications (27)
- Abbott
- Amgen
- Bayer
- Nabi Biopharmaceuticals
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Pennsylvania
- Loma Linda University
- Los Angeles Biomedical Research Institute
- Medical University of Lodz
- Monash University
- Onze Lieve Vrouw Hospital
- RWTH Aachen University
- Saint-Joseph University
- University of Southern California
- Capital Medical University
- Far Eastern Memorial Hospital
- Southeast Renal Research Institute
- University of California, Los Angeles
- University of Central Florida
- University of Angers
- OLV Hospital, Aalst, Belgium
- National Taiwan University
- University of Texas, San Antonio
- University of Antwerp
- People's Liberation Army of China
- Catholic University of Salta
- Universidad Católica de Salta
Organization Involved with Phase 3 Indications (19)
- Pfizer
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Aging (NIA)
- United States Department of Agriculture
- Cedars-Sinai Medical Center
- Ege University
- Hospital Universitari Son Dureta
- Queen's University, Belfast
- Tufts University
- University of Copenhagen
- North Zealand Hospital
- Dialysis Unit Erkelenz, Germany
- KfH Dialysis Centre Aachen, Schurzelter Strasse
- Instituto de Medicina Integral Professor Fernando Figueira
- AZ Sint-Jan
- Arthritis Foundation
- BIOMED
- Federal University of Sao Paulo
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 2 Indications (25)
- United Therapeutics
- Sanofi
- Medice Arzneimittel Pütter GmbH & Co KG
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- National Institute of Environmental Health Sciences (NIEHS)
- Dr. Rachel Holden
- Mahidol University
- Loyola University
- NHS Lothian
- Northwestern University
- Stanford University
- University of Edinburgh
- Utrecht University
- Mayo Clinic
- Columbia University
- Satellite Healthcare
- University of Limoges
- National University of Singapore
- KH Elisabethinen Linz
- George Washington University
- Sanifit
- Clinipace LTD
- Nattopharma
- Government of Singapore
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (16)
- Fresenius
- Genzyme
- Azienda Sanitaria ASL Avellino 2
- Maastricht University
- University of Kentucky
- University of Messina
- University of Athens
- Peking University
- ASL AV/2, Avellino, Italy
- Dialysis, Torre del Greco, Italy
- Sant'Angelo de Lomnardi, Italy
- Dialysis, Avellino, Italy
- Dialysis, Montella, Italy
- San Giuseppe Moscati Hospital
- Washington University in St. Louis
- University of Foggia